Drugs / V0251
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01583738 | Apr 2012 → Apr 2013 | — | Pierre Fabre Laboratories | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V0251 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01583738 ↗ |